Kisqali
Jump to navigation
Jump to search
Kisqali | |
---|---|
Term | Kisqali |
Short definition | Kisqali (kis-KAH-lee) A drug used to treat women with certain types of hormone receptor-positive, HER2-negative breast cancer that is advanced or has spread. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Kisqali - (pronounced) (kis-KAH-lee) A drug used to treat women with certain types of hormone receptor-positive, HER2-negative breast cancer that is advanced or has spread. It is also being studied in the treatment of other types of cancer. Kisqali blocks certain proteins that can prevent cancer cells from growing. It is a type of cyclin-dependent kinase inhibitor. Also called ribociclib succinate
External links
- Medical encyclopedia article on Kisqali
- Wikipedia's article - Kisqali
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski